Pediatric Crohn’s disease from onset to adulthood: granulomas are associated with an early need for immunomodulation

References

• Heresbach D, Alexandre JL, Branger B, Bretagne JF, Cruchant E, Dabadie A, et al. Frequency and significance of granulomas in a cohort of incident cases of Crohn’s disease. Gut 2005;54:215–22.
   PubMed Web of Science ®Google Scholar
• Molnar T, Tiszlavicz L, Gyulai C, Nagy F, Lonovics J. Clinical significance of granuloma in Crohn’s disease. World J Gastroenterol 2005;11:3118–21.
   PubMed Web of Science ®Google Scholar
• Idestrom M, Rubio C, Granath F, Finkel Y, Hugot JP. CARD15 mutations are rare in Swedish pediatric Crohn disease. J Pediatr Gastroenterol Nutr 2005;40:456–60.
   PubMed Web of Science ®Google Scholar
• Freeman HJ. Granuloma-positive Crohn’s disease. Can J Gastroenterol 2007;21:583–7.
   PubMed Web of Science ®Google Scholar
• De Matos V, Russo PA, Cohen AB, Mamula P, Baldassano RN, Piccoli DA. Frequency and clinical correlations of granulomas in children with Crohn disease. J Pediatr Gastroenterol Nutr 2008;46:392–8.
   PubMed Web of Science ®Google Scholar
• Perminow G, Brackmann S, Lyckander LG, Franke A, Borthne A, Rydning A, et al. A characterization in childhood inflammatory bowel disease, a new population-based inception cohort from South-Eastern Norway, 2005-07, showing increased incidence in Crohn’s disease. Scand J Gastroenterol 2009;44:446–56.
   PubMed Web of Science ®Google Scholar
• de Bie CI, Paerregaard A, Kolacek S, Ruemmele FM, Koletzko S, Fell JM, et al. Disease phenotype at diagnosis in pediatric Crohn’s disease: 5-year analyses of the EUROKIDS Registry. Inflamm Bowel Dis 2013;19:378–85.
   PubMed Web of Science ®Google Scholar
• Markowitz J, Kahn E, Daum F. Prognostic significance of epithelioid granulomas found in rectosigmoid biopsies at the initial presentation of pediatric Crohn’s disease. J Pediatr Gastroenterol Nutr 1989;9:182–6.
   PubMed Web of Science ®Google Scholar
• Simillis C, Jacovides M, Reese GE, Yamamoto T, Tekkis PP. Meta-analysis of the role of granulomas in the recurrence of Crohn disease. Dis Colon Rectum 2010;53:177–85.
   PubMed Web of Science ®Google Scholar
• Chambers TJ, Morson BC. The granuloma in Crohn’s disease. Gut 1979;20:269–74.
   PubMed Web of Science ®Google Scholar
• Shaoul R, Karban A, Weiss B, Reif S, Wasserman D, Pacht A, et al. NOD2/CARD15 mutations and presence of granulomas in pediatric and adult Crohn’s disease. Inflamm Bowel Dis 2004;10:709–14.
   PubMed Web of Science ®Google Scholar
• Lee JJ, Escher JC, Shuman MJ, Forbes PW, Delemarre LC, Harr BW, et al. Final adult height of children with inflammatory bowel disease is predicted by parental height and patient minimum height Z-score. Inflamm Bowel Dis 2010;16:1669–77.
   PubMed Web of Science ®Google Scholar
• Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2–6; discussion 16–9.
   PubMedGoogle Scholar
• Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 2001;411:599–603.
   PubMed Web of Science ®Google Scholar
• Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749–53.
   PubMed Web of Science ®Google Scholar
• Levine A, Griffiths A, Markowitz J, Wilson DC, Turner D, Russell RK, et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314–21.
   PubMed Web of Science ®Google Scholar
• Wikland KA, Luo ZC, Niklasson A, Karlberg J. Swedish population-based longitudinal reference values from birth to 18 years of age for height, weight and head circumference. Acta Paediatr 2002;91:739–54.
   PubMed Web of Science ®Google Scholar
• Lindgren G, Strandell A, Cole T, Healy M, Tanner J. Swedish population reference standards for height, weight and body mass index attained at 6 to 16 years (girls) or 19 years (boys). Acta Paediatr 1995;84:1019–28.
   PubMed Web of Science ®Google Scholar
• Tanner JM, Goldstein H, Whitehouse RH. Standards for children’s height at ages 2-9 years allowing for heights of parents. Arch Dis Child 1970;45:755–62.
   PubMed Web of Science ®Google Scholar
• Mahadeva U, Martin JP, Patel NK, Price AB. Granulomatous ulcerative colitis: a re-appraisal of the mucosal granuloma in the distinction of Crohn’s disease from ulcerative colitis. Histopathology 2002;41:50–5.
   PubMed Web of Science ®Google Scholar
• Schmitz-Moormann P, Schag M. Histology of the lower intestinal tract in Crohn’s disease of children and adolescents. Multicentric Paediatric Crohn’s Disease Study. Pathol Res Pract 1990;186:479–84.
   PubMed Web of Science ®Google Scholar
• Pierik M, De Hertogh G, Vermeire S, Van Assche G, Van Eyken P, Joossens S, et al. Epithelioid granulomas, pattern recognition receptors, and phenotypes of Crohn’s disease. Gut 2005;54:223–7.
   PubMed Web of Science ®Google Scholar
• Griffiths AM. Growth retardation in early-onset inflammatory bowel disease: should we monitor and treat these patients differently? Dig Dis 2009;27:404–11.
   PubMed Web of Science ®Google Scholar
• Pigneur B, Seksik P, Viola S, Viala J, Beaugerie L, Girardet JP, et al. Natural history of Crohn’s disease: comparison between childhood- and adult-onset disease. Inflamm Bowel Dis 2010;16:953–61.
   PubMed Web of Science ®Google Scholar
• Vernier-Massouille G, Balde M, Salleron J, Turck D, Dupas JL, Mouterde O, et al. Natural history of pediatric Crohn’s disease: a population-based cohort study. Gastroenterology 2008;135:1106–13.
   PubMed Web of Science ®Google Scholar
• Picco MF, Zubiaurre I, Adluni M, Cangemi JR, Shelton D. Immunomodulators are associated with a lower risk of first surgery among patients with non-penetrating non-stricturing Crohn’s disease. Am J Gastroenterol 2009;104:2754–9.
   PubMed Web of Science ®Google Scholar